Non-Invasive Diagnosis of Nonalcoholic Fatty Liver Disease

2018 ◽  
Vol 113 (10) ◽  
pp. 1409-1411 ◽  
Author(s):  
Masato Yoneda ◽  
Kento Imajo ◽  
Atsushi Nakajima
2019 ◽  
Vol 493 ◽  
pp. S367
Author(s):  
A. Guerra-Ruiz ◽  
A. Maiztegi ◽  
N. Fañanas ◽  
S. Perez ◽  
H. Sentissi ◽  
...  

Medicina ◽  
2019 ◽  
Vol 55 (9) ◽  
pp. 600 ◽  
Author(s):  
Oral ◽  
Sahin ◽  
Turker ◽  
Kocak

Background and objectives: Nonalcoholic fatty liver disease (NAFLD) is associated with multiple factors such as hypertension, diabetes, dyslipidemia, obesity, and hyperuricemia. We aim to investigate the relationship between uric acid and NAFLD in a non-obese and young population. Materials and Methods: This study was performed in January 2010–2019 with a group of 367 (225 patients in the NAFLD group and 142 in the control group) patients with liver biopsy-proven NAFLD or no NAFLD. Patients with NAFLD were classified according to the percentage of steatosis as follows, group I had 1–20% and group II >20%. Demographic, clinical, and laboratory (biochemical parameters) features were collected retrospectively. Results: The mean body mass index (BMI) and age of the patients were 26.41 ± 3.42 and 32.27 ± 8.85, respectively. The BMI, homeostatic model of assessment (HOMA-IR), and uric acid (UA) values of the NAFLD group were found to be significantly higher than those of the controls. A positive correlation was found between the NAFLD stage and UA. The following factors were independently associated with NAFLD: BMI, HOMA-IR, and UA. In addition, the cut-off value of UA was 4.75 mg/dl with a sensitivity of 45.8% and a specificity of 80.3%. Conclusions: UA is a simple, non-invasive, cheap, and useful marker that may be used to predict steatosis in patients with NAFLD.


Kanzo ◽  
2006 ◽  
Vol 47 (9) ◽  
pp. 448-449
Author(s):  
Yasumasa Asamoto ◽  
Hideyuki Hyogo ◽  
Hironori Tokumo ◽  
Haruna Yokomichi ◽  
Eiji Ohara ◽  
...  

2019 ◽  
Author(s):  
Xiuqin An ◽  
Jinchun Liu ◽  
Xiaojuan Zheng ◽  
Zhangfeng Dou ◽  
Yue Li ◽  
...  

Abstract Background/Aims: It was suggested that serum HGF,PCIII and PLT play important roles in nonalcoholic fatty liver disease (NAFLD). Thus, we aimed to evaluate their clinical utility in the diagnosis of patients with suspected NAFLD.Methods:300 Patients with NAFLD were compared to 102 matched controls.All were subjected to history taking, anthropometric measurements, and abdominal ultrasonography, as well as laboratory assessments of liver functions, fasting lipid profile, GLU, serum PLT, HGF and PCIII.Results:The levels of HGF,PCIII and PLT were higher in NAFLD cases than controls ,and with progressive increases as the severity of fatty liver increased(P<0.05).HGF,PCIII and PLT were correlated with various clinical parameters and severity of NAFLD(P<0.05).The optimal cut-off values for HGF in diagnosis of mild, moderate and severe fatty liver were 14.1pg/ml(AUROC 0.753,P=0.004), 15.4pg/ml(AUROC 0.836, P < 0.001), 17.7pg/ml(AUROC 0.903, P < 0.001). PCIII had no value in differentiate mild from moderate fatty liver ,but its ability to diagnose severe fatty liver was significant. A cut-off value for PCIII to diagnose severe fatty liver was 7.9ng/L(AUROC 0.773).The optimal cut-off values for PLT in the diagnosis of mild, moderate and severe fatty liver were 194×10^9/L(AUROC 0.732), 195×10^9/L(AUROC 0.765), 200×10^9/L(AUROC 0.925), respectively with P < 0.001. When three indicators were tested together,the AUROC(95%CI)curve for diagnose NAFLD was 0.881(sensitivity0.760,specificity 0.873)(P<0.001) .Conclusion:.Combined detection of serum HGF, PCIII and PLT may be an effective non-invasive method for diagnosing NAFLD.


2017 ◽  
Vol 25 (5) ◽  
pp. 1054-1062.e5 ◽  
Author(s):  
Rohit Loomba ◽  
Victor Seguritan ◽  
Weizhong Li ◽  
Tao Long ◽  
Niels Klitgord ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document